ACG
OGN icon

Allen Capital Group’s Organon & Co OGN Stock Holding History

Allen Capital Group’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-13,660
Closed -$146K – 285
2025
Q3 		$146K Buy
13,660
+1,892
+16% +$18.6K 0.01% 263
2025
Q2 		$114K Buy
+11,768
New +$121K 0.01% 267
2025
Q1 		– Sell
-10,057
Closed -$150K – 245
2024
Q4 		$150K Buy
+10,057
New +$164K 0.02% 220

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
KBG
Kahn Brothers Group New York $633M AUM 39.01% 1-Year Est. Return

Allen Capital Group's OGN Position: Q4 2025 in Review

Allen Capital Group sold out of Organon & Co (OGN) in Q4 2025, closing a stake of 13,660 shares — an estimated $146K sold.

Allen Capital Group first reported a position in OGN in Q4 2024 and held it in 3 quarters. The position peaked at $150K in Q4 2024. 634 funds tracked by Wall St. Rank hold OGN as of Q4 2025.

  • Allen Capital Group reported no remaining Organon & Co position as of Q4 2025 after selling out during the quarter.
  • Allen Capital Group sold 13,660 Organon & Co shares in Q4 2025, an estimated $146K.
  • Allen Capital Group first reported a position in Organon & Co in Q4 2024 and held it in 3 quarters.
  • Allen Capital Group's Organon & Co position peaked at $150K in Q4 2024.
  • 634 funds tracked by Wall St. Rank held Organon & Co as of Q4 2025.

Based on Allen Capital Group's 13F filing for Q4 2025, filed 9 Feb 2026.